US Drug Watchdog Now Urges Diabetics Who Used The Diabetes Drug Actos And Now Have Bladder Cancer To Get Identified For Possible Legal Help & Compensation

Share Article

The US Drug Watchdog is now saying, "We completely underestimated the number of diabetics, who were using the diabetes drug called Actos, and then developed bladder cancer. We are now urging family members, or loved ones of diabetics, who have been diagnosed with bladder cancer, to ask if they were using the diabetes drug called Actos. Unfortunately, the use of Actos for diabetes, and an elevated chance of bladder cancer could to be related." According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." The US Drug Watchdog says, " We now fear bladder cancer, and diabetics using the diabetes drug called Actos is a much bigger problem than we ever dreamed possible, and we want to hear from any user of the diabetes medication called Actos, if they have developed bladder cancer, to insure they get the best possible legal representation. If after using Actos you, or a loved one developed bladder cancer please call our group immediately at 866-714-6466." http://USDrugWatchdog.Com

News Image
We completely underestimated the number of diabetics, who were using the diabetes drug called Actos, and then developed bladder cancer

The US Drug Watchdog says, "Few people would ever consider the possibility of a drug being used for diabetes, could also be related to elevated cases of bladder cancer. It is for this reason we need the help of loved ones, or family members of diabetics, who now have bladder cancer, to ask if the diabetic was, or is using the diabetes drug called Actos. There appears to be a correlation between US diabetics, bladder cancer, and the drug called Actos, and we want to identify every possible victim, in the hopes we can get them some meaningful help." Actos is a member of a class of drugs known as thiazolidinediones, which have been linked to bladder cancer. Actos side effects include increased risk of congestive heart failure, and an increased risk for bladder cancer. According to the AP, "The US FDA has also issued a warning about Actos, and bladder cancer. Both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." For more information Actos users, who now have bladder cancer, or their loved ones are encouraged to call the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. If you have a friend, or loved one, who was, or is using the diabetes drug called Actos, who has developed bladder cancer, please have them call us at 866-714-6466." http://USDrugWatchdog.Com

The US Drug Watchdog is the premier private pharmaceutical watchdog in the United States. The group says, "Tragically the Internet is loaded with misleading ads about Actos use, and bladder cancer compensation, lawsuits, or class actions. Unfortunately, most of the attorneys or law firms advertising for help with the diabetes drug called Actos, and bladder cancer are middlemen marketing law firms--not the actual trial law firms that will prosecute these cases." They say, "We want to make certain all Actos bladder cancer victims get to the actual trial law firms or attorneys that have the best record in achieving superior results for their clients--period--no middleman marketing law firms, or attorneys." For more information please contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at http://USDrugWatchdog.com

Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

M Thomas Martin
Americas Watchdog
866-714-6466
Email >
Visit website

Media